Dawson James Starts Synergetics USA (SURG) at Buy; SURG-ing ahead
Tweet Send to a Friend
Dawson James initiates coverage on Synergetics USA (NASDAQ: SURG) with a Buy. PT $6.25.
Dawson analyst says, "Since new top ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Dawson analyst says, "Since new top ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
